| II-68 Chiara Zecchin Quantitative modelling to assess target engagement and pharmacology in early clinical development of an anti-OSM humanised mAb Wednesday 15:10-16:30 |
| II-68 Chiara Zecchin Quantitative modelling to assess target engagement and pharmacology in early clinical development of an anti-OSM humanised mAb Wednesday 15:10-16:30 |